YY/T 0870.3-2013Test for genotoxicity of medical devices - Part 3: In vitro mammalian cell gene mutation test using mouse lymphoma cell (English PDF)
医疗器械遗传毒性试验 第3部分:用小鼠淋巴瘤细胞进行的体外哺乳动物细胞基因突变试验
This is a limited preview
Buy now to download the full PDF (15 pages)
Need quotation for your management?
Get a formal quotation for YY/T 0870.3-2013 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
October 21, 2013
Implementation date
October 1, 2014
Scope
YY/T 0870.3-2013 is the English-translated version of 医疗器械遗传毒性试验 第3部分:用小鼠淋巴瘤细胞进行的体外哺乳动物细胞基因突变试验.
YY/T 0870.3-2013 is the Chinese standard "Test for genotoxicity of medical devices - Part 3: In vitro mammalian cell gene mutation test using mouse lymphoma cell".
Its scope clause reads: This section of YY/T 0870 specifies the use of the mouse lymphoma cell line (L5178YTK /-3.7.2C) for medical devices/materials. Method for in vitro mammalian cell gene mutation assay.
This section applies to the TK gene mutation test using the mouse lymphoma cell line (L5178YTK /-3.7.2C) using the microplate method. A method of assessing cytotoxicity using both relative survival (RS) and relative total growth (RTG) indicators.
Note 1. In vitro mammalian cell gene mutation test of oral materials can be found in YY/T 0127.17. Note 2. In vitro mammalian cell gene mutation testing of nanomaterials may require specific revisions to the methods in this section, but this section does not give description. Its clauses include terms and definitions.
Found what you need?
Document preview — YY/T 0870.3-2013
National Standard of the People's Republic of China
Issued by: National Medical Products Administration of the People's Republic of China
Contents
- 1 Scope
- 2 Normative references
- 3 Terms and definitions
- 3.1 Cloning efficiency
- 3.2 Chromosome cleavage agent clastogen
- 3.3 Forward mutation
- 3.4 Frameshift mutant
- 3.5 Mitotic recombination
1 Scope
This section of YY/T 0870 specifies the use of the mouse lymphoma cell line (L5178YTK /-3.7.2C) for medical devices/materials.
Method for in vitro mammalian cell gene mutation assay.
This section applies to the TK gene mutation test using the mouse lymphoma cell line (L5178YTK /-3.7.2C) using the microplate method.
A method of assessing cytotoxicity using both relative survival (RS) and relative total growth (RTG) indicators.
Note 1. In vitro mammalian cell gene mutation test of oral materials can be found in YY/T 0127.17.
Note 2. In vitro mammalian cell gene mutation testing of nanomaterials may require specific revisions to the methods in this section, but this section does not give description.
2 Normative references
The following documents are indispensable for the application of this document. For dated references, only dated versions apply to this article.
Pieces. For undated references, the latest edition (including all amendments) applies to this document.
GB/T 16886.1 Biological evaluation of medical devices - Part 1. Evaluation and testing in the process of risk management
GB/T 16886.3 Biological evaluation of medical devices - Part 3. Tests for genotoxicity, carcinogenicity and reproductive toxicity
GB/T 16886.12 Biological evaluation of medical devices - Part 12. Sample preparation and reference materials
3 Terms and definitions
The following terms and definitions as defined in GB/T 16886.1, GB/T 16886.3 and GB/T 16886.12 apply to this document.
3.1 Cloning efficiency
Cells seeded at low density grew to a percentage of countable colonies.
3.2 Chromosome cleavage agent clastogen
Any substance that causes aberrations in the chromosome structure of a cell or organism.
3.3 Forward mutation
Transformation from a prototype (wild type) to a mutant gene mutation can cause changes in enzyme activity and encoded proteins.
3.4 Frameshift mutant
A substance that causes an increase or decrease in single or multiple base pairs in a DNA molecule.
3.5 Mitotic recombination
During mitosis, recombination between homologous chromatids may induce DNA double-strand breaks or loss of heterozygosity.
YY/T 0916.7-2024 | YY/T 0841-2023 | YY/T 0916.1-2021 | YY/T 0870.8-2024 | YY/T 0870.7-2023 | YY/T 0870.6-2019 | […]
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 15 pages — is available in the English PDF.
Similar standards
How to Download YY/T 0870.3-2013
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Fast delivery
After payment you'll receive an email confirmation. The English PDF is sent to the same address, usually within minutes and at the latest within 1 business day.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
YY/T 0870.4-2014 — Test for genotoxicity of medical devices - Part 4: Mammalian bone marrow erythrocyte micronucleus test
YY/T 0870.2-2013 — Test for genotoxicity of medical devices - Part 2: In vitro mammalian chromosome aberration test
YY/T 0870.5-2014 — Test for genotoxicity of medical devices - Part 5: Mammalian bone marrow chromosome aberration test
YY/T 0870.3-2013
$165.00